Physician profile
Scott T Koppel
NPI 1295732741
$5,793.66
in general payments reported to CMS, 2019-2025
26 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $992 · 2020: $639 · 2021: $2,051 · 2022: $646 · 2023: $375 · 2024: $622 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,446.69 | 2019-2025 | Affinity, Apligraf, Puraply Wound Matrix |
| Arthrex, INC. | $1,200.00 | 2021 | |
| Medtronic, INC. | $714.67 | 2021-2025 | Closurefast, Venaseal |
| Smith+Nephew, INC. | $403.45 | 2019-2024 | Collagenase Santyl |
| Integra Lifesciences Corporation | $365.49 | 2019-2020 | |
| Medtronic Vascular, INC. | $272.05 | 2019-2020 | |
| Stimwave Technologies Incorporated | $243.12 | 2020-2021 | |
| Kerecis Limited | $142.40 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bioventus LLC | $127.05 | 2019-2022 | |
| Angiodynamics, INC. | $124.19 | 2022 | |
| Horizon Therapeutics Plc | $97.75 | 2019-2020 | |
| Paragon 28, INC. | $94.04 | 2019 | |
| Zyla Life Sciences, INC. | $86.27 | 2019 | |
| Amgen INC. | $71.46 | 2024-2025 | Krystexxa |
| Cashflow Solutions, LLC | $57.77 | 2022-2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $56.69 | 2020-2021 | |
| Convatec INC. | $54.73 | 2023 | |
| Bard Peripheral Vascular, INC. | $50.77 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.63 | 2022-2023 | Jublia |
| Djo, LLC | $26.53 | 2019 | |
| Next Science LLC | $25.00 | 2024 | Xperience, Blastx, Surgx |
| Janssen Pharmaceuticals, INC | $22.10 | 2021 | |
| Abbvie INC. | $21.27 | 2021 | |
| Paratek Pharmaceuticals, INC. | $20.83 | 2024 | Nuzyra |
| Kci USA, INC. | $15.39 | 2021 | |
| Highridge Medical LLC | $15.32 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Koppel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.